Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Transaction in Own Shares

30 Jul 2021 18:15

Transaction in Own Shares

Octopus AIM VCT plc (“the Company”)

30 July 2021

Purchase of own securities and total voting rights

Octopus AIM VCT plc announces that on 30 July 2021 the Company purchased for cancellation 543,809 Ordinary shares at a price of 119.3p per share.

Following this transaction, the issued share capital of the Company will consist of 143,325,209 Ordinary shares with a nominal value of £0.01 each, with voting rights.

For further enquiries, please contact:

Uloma Adighibe

Octopus Company Secretarial Services LimitedTel: 020 3935 4186

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.